At A Glance: This Prescriber in 2011
Self-Reported Primary Specialty
Rank: 21 out of 558
Rank: 17 out of 558
How Does This Prescriber Compare to Peers?
in New York
Antipsychotics to Seniors
Dangerous Drugs to Seniors
Brand Name Drugs
50% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.
$111 was the average price of a prescription from this provider, compared to $93 among peers.
Prescriptions per Patient
9 is the average number of prescriptions (including refills) per patient, compared to an average of 5.
This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.
KEY: How to read this
Hover to see more prescribers
This Prescriber's Drugs
Search for a Drug
5 questions to ask about a new drug »
via Consumer Health Choices
Compare different prescription drugs »
via Consumer Reports
Click to Filter by Category
A narcotic drug. More » Misuse and abuse of narcotics led to some 16,000 overdose deaths in 2010.
This provider is among the top 10 prescribers of
this drug in the country.
This Drug's Rank
Total Prescriptions Filled
|Category||For this Prescriber||
For All Prescribers in
This Specialty in New York
Treats problems with urinat... +
Treats problems with urination caused by an enlarged prostate (benign prostatic hyperplasia or BPH). This medicine is used alone or may be combined with tamsulosin (Flomax). More info »
Tamsulosin is used in men t... +
Tamsulosin is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia or BPH) which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency. Tamsulosin is in a class of medications called alpha blockers. It works by relaxing the muscles in the prostate and bladder so that urine can flow easily. More info »
Treats an enlarged prostate... +
Treats an enlarged prostate (benign prostatic hyperplasia or BPH) in men and causes hair growth in male pattern baldness. It may be used alone or in combination with other medicines such as an alpha-blocker (doxazosin, Cardura? to treat BPH. This medicine is a 5-alpha-reductase inhibitor. More info »
Doxazosin (Cardura, Cardura... +
Doxazosin (Cardura, Cardura XL) is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia or BPH), which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency. Doxazosin (Cardura) is also used alone or in combination with other medications to treat high blood pressure. Doxazosin is in a class of medications called alpha-blockers. It relieves the symptoms of BPH by relaxing the muscles of the bladder and prostate. It lowers blood pressure by relaxing the blood vessels so that blood can flow more easily through the body. More info »
Treats problems with urinat... +
Treats problems with urination caused by an enlarged prostate (also called benign prostatic hyperplasia or BPH). This medicine is an alpha-blocker. More info »
Solifenacin is used to trea... +
Solifenacin is used to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Solifenacin is in a class of medications called anticholinergics. It works by relaxing the bladder muscles to prevent urgent, frequent, or uncontrolled urination. More info »
Treats symptoms of an overa... +
Treats symptoms of an overactive bladder such as incontinence (loss of bladder control) or a frequent need to urinate by helping you have more control over the need to urinate. More info »
About This Data
- No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
- This provider's address and specialty information was last updated on Dec. 23, 2011.